Twenty-four studies focused on severe AKI (AKI stage 2 or 3), and the diagnostic accuracy was numerically highest for TIMP-2 × IGFBP-7: custom (DOR 19.6, 95% CI 7.0–55.3), and serum NGAL (DOR 11.5, 95% CI 6.1–21.9) (Additional file 1: Table S5). This evidence concerns the gene IGFBP7 and acute kidney injury.